Acadian Asset Management LLC increased its holdings in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 1.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,160,661 shares of the electronics maker’s stock after acquiring an additional 19,840 shares during the period. Acadian Asset Management LLC owned about 1.21% of Dolby Laboratories worth $86,172,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the business. Cheviot Value Management LLC purchased a new stake in Dolby Laboratories in the first quarter worth $27,000. MAI Capital Management grew its holdings in shares of Dolby Laboratories by 87.1% in the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Dolby Laboratories in the 1st quarter worth about $29,000. Ameritas Advisory Services LLC purchased a new position in Dolby Laboratories in the 2nd quarter worth about $48,000. Finally, Atlantic Union Bankshares Corp bought a new stake in Dolby Laboratories during the 2nd quarter valued at about $50,000. Institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Price Performance
Shares of DLB stock opened at $65.11 on Friday. The stock’s 50-day moving average is $69.89 and its 200 day moving average is $73.03. Dolby Laboratories has a 1-year low of $64.38 and a 1-year high of $89.66. The company has a market cap of $6.24 billion, a P/E ratio of 23.85 and a beta of 0.97.
Analyst Ratings Changes
View Our Latest Stock Report on Dolby Laboratories
Insider Transactions at Dolby Laboratories
In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at $7,901,110.75. This represents a 17.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 82,000 shares of company stock worth $5,845,440 over the last 90 days. Company insiders own 38.39% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More
- Five stocks we like better than Dolby Laboratories
- Best Stocks Under $10.00
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Golden Cross Stocks: Pattern, Examples and Charts
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- How is Compound Interest Calculated?
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
